Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4074 Target Snapshot

Angiotensin-converting enzyme · SINGLE PROTEIN · Oryctolagus cuniculus

1,744Compounds
137Assays
11Approved Drugs
2,501.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P12822. Use UniProt P12822 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P12822 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Angiotensin-converting enzyme as ChEMBL target CHEMBL4074, mapped to UniProt P12822. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Angiotensin-converting enzyme
SINGLE PROTEIN · Oryctolagus cuniculus
As of 2026-09-13
ChEMBL target ID
CHEMBL4074
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P12822
Angiotensin-converting enzyme
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Angiotensin-converting enzyme is the right protein anchor across sources, using UniProt P12822 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAngiotensin-converting enzyme
UniProt AccessionP12822
Component TypeProtein
Sequence Length1310 aa

Angiotensin-converting enzyme

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Angiotensin-converting enzyme, mapped to UniProt P12822. Sequence length is 1310 aa.

Mapped IDP12822
Review nameAngiotensin-converting enzyme
OrganismOryctolagus cuniculus
Clinical Profile

Clinical Phase Distribution

11
Approved
10
Phase II
Assay Mix

Activity Type Distribution

IC501,594.0
KI907.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL112589 10.68 IC50 0.021 Preclinical
CHEMBL113612 10.68 IC50 0.021 Preclinical
CHEMBL324898 10.6 IC50 0.025 Preclinical
CHEMBL323879 10.55 IC50 0.028 Preclinical
CHEMBL112922 10.1 IC50 0.08 Preclinical
CHEMBL554951 10.05 IC50 0.09 Preclinical
CHEMBL114018 10.0 IC50 0.1 Preclinical
CHEMBL324676 10.0 IC50 0.1 Preclinical
CHEMBL324703 10.0 IC50 0.1 Preclinical
CHEMBL115153 10.0 IC50 0.1 Preclinical
Distribution

pChEMBL Value Distribution

38
5.0
31
5.5
66
6.0
83
6.5
109
7.0
141
7.5
100
8.0
29
8.5
4
9.0
4
9.5
pChEMBL
Approved Drugs

Approved Drugs

BENAZEPRIL
CHEMBL838
Approved 1991
QUINAPRIL
CHEMBL1592
Approved 1991
RAMIPRIL
CHEMBL1168
Approved 1991
ENALAPRILAT ANHYDROUS
CHEMBL577
Approved 1988
LISINOPRIL ANHYDROUS
CHEMBL1237
Approved 1987
ENALAPRIL
CHEMBL578
Approved 1985
CAPTOPRIL
CHEMBL1560
Approved 1981
Assay Landscape

Assay Landscape

137
Total Assays
653
Tested Compounds
3
Assay Types
Binding — 131 assays, 653 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 109 533 7.1
tissue-based format 13 120 7.1
organism-based format 9 0
Functional — 5 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 5 0
ADME — 1 assays, 3 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 3 4.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine